Search Results - "Romero Pinel, Lucía"
-
1
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates
Published in Multiple sclerosis (01-12-2018)“…Background: Population-based studies on neuromyelitis optica spectrum disorders (NMOSD) are limited, and it is unclear whether the rates have changed with the…”
Get full text
Journal Article -
2
Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator
Published in PloS one (29-04-2022)“…The efficacy and safety of disease-modifying therapies (DMTs) in multiple sclerosis (MS) are well known; however, owing to their high costs, determining…”
Get full text
Journal Article -
3
Kappa free light chains index in multiple sclerosis very long-term prognosis
Published in Frontiers in immunology (11-10-2023)“…IntroductionThe role of the kappa-free light chain (kFLC) in the diagnosis of multiple sclerosis (MS) and, to a lesser extent, its role as a medium-term…”
Get full text
Journal Article -
4
Quantifying the patient´s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire
Published in PloS one (29-07-2021)“…The assessment of self-reported outcomes in neuromyelitis optica spectrum disorder (NMOSD) is limited by the lack of validated disease-specific measures. The…”
Get full text
Journal Article -
5
Baseline MxA mRNA expression predicts interferon beta response in multiple sclerosis patients
Published in PloS one (14-11-2014)“…Myxovirus resistance protein A (MxA) is a molecule induced after interferon-beta injection, mostly used to evaluate its bioactivity. There is little available…”
Get full text
Journal Article -
6
Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series
Published in BMC neurology (03-10-2013)“…In 2002, the Transverse Myelitis Consortium Working Group (TMCWG) proposed the diagnostic criteria for idiopathic acute transverse myelitis (IATM) to delimit…”
Get full text
Journal Article -
7
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)
Published in Revista de neurologiá (2023)Get full text
Journal Article -
8
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)
Published in Revista de neurologiá (2023)Get full text
Journal Article -
9
XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (II)
Published in Revista de neurologiá (16-06-2021)Get full text
Journal Article -
10
XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (I)
Published in Revista de neurologiá (01-06-2021)Get full text
Journal Article -
11
Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing–remitting multiple sclerosis: a 20-year follow-up cohort
Published in Journal of neurology (01-04-2024)“…Background and objectives Serum biomarkers are emerging as useful prognostic tools for multiple sclerosis (MS); however, long-term studies are lacking. We…”
Get full text
Journal Article -
12
The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades
Published in Multiple sclerosis and related disorders (01-12-2022)“…•Relapsing-remitting multiple sclerosis (RRMS) onset usually occurs between age 20 and 40 years.•This study investigated how age at RRMS onset has changed over…”
Get full text
Journal Article -
13
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
Published in Multiple sclerosis (01-04-2015)“…Objective: To investigate glial and neuronal biomarkers in cerebrospinal fluid (CSF) samples from patients with relapsing–remitting multiple sclerosis (RRMS)…”
Get full text
Journal Article -
14
Natalizumab continuation versus switching to ocrelizumab after PML risk stratification in RRMS patients: a natural experiment
Published in Journal of neurology (01-05-2023)“…Background Natalizumab (NTZ) and ocrelizumab (OCR) can be used for the treatment of relapsing–remitting multiple sclerosis (RRMS). In patients treated with…”
Get full text
Journal Article -
15
XII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2019 (II)
Published in Revista de neurologiá (15-06-2020)Get full text
Journal Article -
16
Assessment of the Multiple Sclerosis Severity Score and the Age-Related Multiple Sclerosis Severity Score as health indicators in a population-based cohort
Published in Neurological sciences (17-09-2024)“…People with multiple sclerosis (MS) present varying degrees of disability throughout their disease course. The Multiple Sclerosis Severity Score (MSSS) and the…”
Get full text
Journal Article -
17
XII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2019 (I)
Published in Revista de neurologiá (2020)Get full text
Journal Article -
18
Fingolimod-associated progressive multifocal leukoencephalopathy in a multiple sclerosis patient with a good response to filgrastim
Published in Journal of neurology (01-11-2023)Get full text
Journal Article -
19
Revisión de las novedades presentadas en el Congreso ECTRIMS 2018: XI Reunión Post-ECTRIMS (II)
Published in Revista de neurologiá (01-06-2019)Get full text
Journal Article -
20
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis
Published in Brain (London, England : 1878) (05-08-2024)“…The potential of combining serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels to predict disability worsening in…”
Get full text
Journal Article